Evidence map›Paper›PMID 29715275›Full record

ArticlePloS one2018

Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma.

Jennifer Teichman, Lorin Dodbiba, Henry Thai, Andrew Fleet, Trevor Morey, Lucy Liu, Madison McGregor, Dangxiao Cheng, Zhuo Chen, Gail Darling and 10 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Esophageal adenocarcinoma models: a closer look.Frontiers in molecular biosciences · 2024
    Review
  4. Review
  5. Review
  6. PRKCI Mediates RadiosensitivityFrontiers in oncology · 2022
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Jennifer TeichmanPostgraduate Medical Education, University of Toronto, Toronto, Canada.ORCID 0000-0002-7538-5772
Lorin DodbibaDepartment of Medical Biophysics, University of Toronto, Toronto, Canada.
Henry ThaiPrincess Margaret Cancer Centre, Toronto, Canada.
Andrew FleetPrincess Margaret Cancer Centre, Toronto, Canada.
Trevor MoreyPostgraduate Medical Education, University of Toronto, Toronto, Canada.
Lucy LiuDepartment of Medical Biophysics, University of Toronto, Toronto, Canada.
Madison McGregorPrincess Margaret Cancer Centre, Toronto, Canada.
Dangxiao ChengPrincess Margaret Cancer Centre, Toronto, Canada.
Zhuo ChenPrincess Margaret Cancer Centre, Toronto, Canada.
Gail DarlingDepartment of Thoracic Surgery, University Health Network, Toronto, Canada.
Yonathan BrhaneDivision of Biostatistics, Dalla Lana School of Public Health, Toronto, Canada.
Yuyao SongDivision of Biostatistics, Dalla Lana School of Public Health, Toronto, Canada.
Osvaldo Espin-GarciaDivision of Biostatistics, Dalla Lana School of Public Health, Toronto, Canada.
Wei XuPrincess Margaret Cancer Centre, Toronto, Canada.
Hala GirgisDepartment of Laboratory Medicine and Pathobiology, Toronto, Canada.
Joerg SchwockDepartment of Laboratory Medicine and Pathobiology, Toronto, Canada.
Helen MacKayDepartment of Medicine, Division of Medical Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada.
Robert BristowDepartment of Medical Biophysics, University of Toronto, Toronto, Canada.
Laurie AillesDepartment of Medical Biophysics, University of Toronto, Toronto, Canada.
Geoffrey LiuDepartment of Medical Biophysics, University of Toronto, Toronto, Canada.
University of Toronto · CAPrincess Margaret Cancer Centre · CAPublic Health Ontario · CASunnybrook Health Science Centre · CAUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Hedgehog (Hh) signaling pathway is active in esophageal adenocarcinoma (EAC). We used a patient-derived murine xenograft (PDX) model of EAC to evaluate tumour response to conventional treatment with radiation/chemoradiation with or without Hh inhibition. Our goal was to determine the potential radioresistance effects of Hh signaling and radiosensitization by Hh inhibitors.

methodsPDX models were treated with radiation, chemotherapy or combined chemoradiation. Tumour response was measured by growth delay. Hh transcript levels (qRT-PCR) were compared among frozen tumours from treated and control mice. 5E1, a monoclonal SHH antibody, or LDE225, a clinical SMO inhibitor (Novartis®) inhibited Hh signaling.

resultsPrecision irradiation significantly delayed xenograft tumour growth in all 7 PDX models. Combined chemoradiation further delayed growth relative to either modality alone in three of six PDX models. Following irradiation, two of three PDX models demonstrated sustained up-regulation of Hh transcripts. Combined LDE225 and radiation, and 5E1 alone delayed growth relative to either treatment alone in a Hh-responsive PDX model, but not in a non-responsive model.

conclusionHh signaling mediates the radiation response in some EAC PDX models, and inhibition of this pathway may augment the efficacy of radiation in tumours that are Hh dependent.

Indexed as

ChemoradiotherapyAdenocarcinomaAnimalsApoptosisBiphenyl CompoundsCell ProliferationEsophageal NeoplasmsGene Expression Regulation, NeoplasticHedgehog ProteinsHumansMiceMice, Inbred NODMice, SCIDPyridinesRadiation ToleranceTumor Cells, CulturedBiphenyl CompoundsHedgehog ProteinsPyridinessonidegib

Identifiers

PMID29715275
PMCPMC5929523
OpenAlexW2800215052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.